Company
Beijing VDJBio Co., LTD.
Beijing VDJBio Co., LTD. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Recombinant Human Interleukin-2 Fusion Protein with Human Serum Albumin (VDJ010) | Phase 1 | Ulcerative Colitis (UC) |
Latest
No recent events.
Follow Beijing VDJBio Co., LTD. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.